Axa’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-102,835
Closed -$6.76M 1186
2023
Q1
$6.76M Sell
102,835
-71,862
-41% -$4.44M 0.02% 489
2022
Q4
$7.86M Buy
174,697
+1,575
+0.9% +$85.6K 0.03% 490
2022
Q3
$12.5M Sell
173,122
-7,188
-4% -$714K 0.05% 381
2022
Q2
$19.3M Sell
180,310
-1,865
-1% -$190K 0.07% 302
2022
Q1
$20.2M Sell
182,175
-44,483
-20% -$4.64M 0.06% 360
2021
Q4
$29M Sell
226,658
-11,190
-5% -$1.44M 0.07% 287
2021
Q3
$31.6M Sell
237,848
-8,600
-3% -$1.07M 0.09% 253
2021
Q2
$26.6M Sell
246,448
-10,229
-4% -$1.1M 0.08% 293
2021
Q1
$27M Buy
256,677
+2,368
+0.9% +$264K 0.08% 284
2020
Q4
$26.5M Buy
254,309
+10,739
+4% +$1.04M 0.08% 265
2020
Q3
$20.9M Sell
243,570
-32,327
-12% -$2.73M 0.08% 281
2020
Q2
$20.2M Sell
275,897
-28,466
-9% -$1.93M 0.08% 265
2020
Q1
$15.8M Buy
304,363
+71,326
+31% +$3.89M 0.08% 262
2019
Q4
$13.1M Buy
233,037
+37,750
+19% +$1.92M 0.05% 382
2019
Q3
$9.31M Sell
195,287
-49,852
-20% -$2.68M 0.04% 496
2019
Q2
$13.3M Sell
245,139
-31,436
-11% -$1.44M 0.05% 393
2019
Q1
$11.2M Buy
276,575
+27,643
+11% +$1.08M 0.04% 431
2018
Q4
$7.76M Buy
248,932
+48,253
+24% +$1.86M 0.03% 486
2018
Q3
$9.14M Buy
200,679
+5,937
+3% +$251K 0.03% 504
2018
Q2
$8.16M Hold
194,742
0.03% 516
2018
Q1
$8M Buy
+194,742
New +$8.29M 0.03% 520

Other funds holding CTLT

Axa's CTLT Position: Q2 2023 in Review

Axa sold out of CATALENT, INC. (CTLT) in Q2 2023, closing a stake of 102,835 shares — an estimated $6.76M sold.

Axa first reported a position in CTLT in Q1 2018 and held it in 21 quarters. The position peaked at $31.6M in Q3 2021. 441 funds tracked by Wall St. Rank hold CTLT as of Q2 2023.

  • Axa reported no remaining CATALENT, INC. position as of Q2 2023 after selling out during the quarter.
  • Axa sold 102,835 CATALENT, INC. shares in Q2 2023, an estimated $6.76M.
  • Axa first reported a position in CATALENT, INC. in Q1 2018 and held it in 21 quarters.
  • Axa's CATALENT, INC. position peaked at $31.6M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2023.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.